Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Options markets are flashing mixed signals this week. Chip stocks attract the heaviest negative bets while a set of large-cap defensives sees unusually one-sided bullish positioning.
NVDA tops the negative options flow table over the past seven days. AMD and MU follow closely. All three sit in the semiconductor space, which has seen fierce two-way options action as earnings season accelerates. The chip rebound stalled again Monday, with the S&P 500 closing lower as AI-linked names pulled back.
On the bullish side, ORTEX screening shows 100% positive options flow over seven days for ADP, Equinix, and . That sweep of defensive and infrastructure names suggests hedgers are rotating out of pure-tech exposure.
MRNA sits in an interesting position. The ORTEX Index Rebalance Radar puts an 81% probability on Moderna re-entering MSCI World and MSCI North America. A confirmed addition would require $3.3 billion of forced buying. That is just 0.8 days of normal volume, creating a sharp impact window. The announcement is expected 11 November.
XEL is one name worth watching for options traders tracking real-economy catalysts. ORTEX alt data recorded Xcel Energy's reactor output at 10.0 standard deviations below its own history as of 10 October. That is the sharpest nuclear output drop in the dataset. Power supply shocks of that magnitude can move near-dated options pricing quickly for utility names.
ACV Auctions (ACVA) faces $227 million of forced index selling from Russell 2000 alone if Copart's tender completes. ORTEX puts the completion probability at 93%. With ACVA carrying 5.4% daily volatility, options premium in this name looks notably elevated relative to peers.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
